Prognostic factors in HLA matched related allogeneic transplant for relapsed acute myeloid leukemia.

被引:0
|
作者
Moulder, SL [1 ]
Arrowsmith, ER [1 ]
Stein, RS [1 ]
Goodman, SA [1 ]
Morgan, DS [1 ]
Brandt, SJ [1 ]
Greer, JP [1 ]
Wolff, SN [1 ]
机构
[1] Vanderbilt Univ, Nashville, TN USA
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
4951
引用
收藏
页码:385B / 385B
页数:1
相关论文
共 50 条
  • [31] Relevance of vitamin D in patients undergoing HLA matched allogeneic stem cell transplant for acute leukemia
    Jindal, Nishant
    Saroha, Megha
    Mirgh, Sumeet
    Chichra, Akanksha
    Nayak, Lingaraj
    Bonda, Avinash
    Gokarn, Anant
    Punatar, Sachin
    Bagal, Bhausaheb
    Chavan, Preeti
    Mathew, Libin Jacob
    Kannan, Sadhana
    Khattry, Navin
    TRANSPLANT IMMUNOLOGY, 2023, 81
  • [32] Allogeneic hematopoietic stem cell transplantation from matched related donors for acute myeloid leukemia
    Galffy, Balazs
    Sopko, Ladislav
    Lukas, Jozef
    Martisova, Michaela
    Ziakova, Barbora
    Rohon, Peter
    Cingelova, Silvia
    Mistrik, Martin
    Bojtarova, Eva
    Batorova, Angelika
    BRATISLAVA MEDICAL JOURNAL-BRATISLAVSKE LEKARSKE LISTY, 2024, 125 (09): : 551 - 557
  • [33] LONG-TERM FOLLOW-UP OF PATIENTS UNDERGOING ALLOGENEIC TRANSPLANT FOR THERAPY-RELATED ACUTE MYELOID LEUKEMIA. EXPERIENCE OF THE ROME TRANSPLANT NETWORK
    Ceresoli, E.
    Cerretti, R.
    Picardi, A.
    De Angelis, G.
    Ciangola, G.
    Meconi, F.
    Paterno, G.
    Buccisano, F.
    Chierichini, A.
    Ferrari, A.
    Tirindelli, M. C.
    Romano, A.
    Dentamaro, T.
    Cimino, G.
    Arcese, W.
    Cudillo, L.
    HAEMATOLOGICA, 2017, 102 : 149 - 149
  • [34] Prognostic factors and impact of CMV reactivation on acute myeloid leukemia patients after HLA-matched myeloablative allogeneic stem cell transplantation in a high CMV prevalence country
    Chanswangphuwana, Chantiya
    Wudhikarn, Kitsada
    Watanaboonyongcharoen, Phandee
    Kansuwan, Patsita
    Sukperm, Autcharaporn
    Bunworasate, Udomsak
    HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2023, 45 : S51 - S56
  • [35] Acute myeloid leukemia.: Reply
    Löwenberg, B
    Burnett, AK
    NEW ENGLAND JOURNAL OF MEDICINE, 2000, 342 (05): : 358 - 359
  • [36] Cytogenetics in acute myeloid leukemia.
    Schoch C.
    Haferlach T.
    Current Oncology Reports, 2002, 4 (5) : 390 - 397
  • [37] Hypoplastic acute myeloid leukemia.
    Park, Hye-Won
    Lee, Je-Hwan
    Choi, Seong-Jun
    Lee, Jung-Hee
    Seol, Miee
    Lee, Young-Shin
    Ryu, Seong-Gil
    Kim, Keum Hee
    Jang, Seongsoo
    Seo, Eul-Joo
    Park, Chan-Jeoung
    BLOOD, 2006, 108 (11) : 202B - 202B
  • [38] MISMATCHED DONOR LYMPHOCYTE INFUSIONS FOR RELAPSED ACUTE LEUKEMIA FOLLOWING HLA IDENTICAL ALLOGENEIC STEM CELL TRANSPLANT
    Melver, Z. A.
    Battiwalla, M.
    Barrett, A. J.
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2011, 17 (02) : S215 - S215
  • [39] FLAG-(IDA)-Mylotarg in the therapy of relapsed and refractory acute myeloid leukemia.
    Fabbiano, F
    Mondello, F
    Magrin, S
    Felice, R
    Marino, C
    Turri, D
    Mirto, S
    BLOOD, 2005, 106 (11) : 236B - 236B
  • [40] Cytoreduction with gemtuzumab ozogamicin and cytarabine prior to allogeneic stem cell transplant for relapsed/refractory acute myeloid leukemia
    Wang, Eunice S.
    Zeidan, Amer
    Tan, Wei
    Wilding, Gregory E.
    Ford, Laurie Ann
    Wallace, Paul K.
    Hahn, Theresa E.
    Battiwalla, Minoo
    McCarthy, Philip L.
    Wetzler, Meir
    LEUKEMIA & LYMPHOMA, 2012, 53 (10) : 2085 - 2088